ESLAW vs ULTA
Estrella Immunopharma Inc. (ESLAW) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
ESLAW does not have a complete income-statement cache yet.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
ESLAW currently screens at market cap $0. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the ESLAW and ULTA stock pages for the full models.
Not investment advice.